Agios Pharmaceuticals AGIO
NASDAQ AGIO
$31.80 -0.68 (-2.09%)
At close: Oct 2, 2026 · 4:00 PM EDT

Agios Pharmaceuticals (AGIO) Selling, General & Administrative (2012 - 2026)

Updated

Agios Pharmaceuticals (AGIO) reported Selling, General & Administrative of $51.55 million for Q2 2026, up 12.4% from $45.87 million a year earlier and up 6.7% from the prior quarter.

Analysis

Agios Pharmaceuticals (AGIO) Selling, General & Administrative (2012 - 2026) Analysis & Trends

Over the twelve months ended Jun 30, 2026, Agios Pharmaceuticals' Selling, General & Administrative came in at $192.74 million, up 8.5% year-over-year; for FY2025, it came in at $180.28 million, up 15.0% from FY2024.

  • Selling, General & Administrative has a five-year compound annual growth rate of 9.4% (FY2020 to FY2025).
  • By year, Selling, General & Administrative came in at $156.78 million in FY2024 (+30.8%), $119.9 million in FY2023 (-1.5%), $121.67 million in FY2022 (+0.2%) and $121.45 million in FY2021 (+5.5%).
  • Five-year quarterly Selling, General & Administrative spans a low of $25.82 million in Q3 2023 and a high of $51.7 million in Q4 2024.
  • Year over year, Selling, General & Administrative gained in seven of the last eight quarters, with growth averaging 24.3%.
  • The high point for year-over-year Selling, General & Administrative in five years was Q3 2024 (growth of 49.2%); the low point was Q3 2023 (a decline of 11.3%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $48.3 million (Q1 2026), $51.61 million (Q4 2025) and $41.27 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 6.43 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 3.63 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -5.65 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 1.92 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 3.41 Bn
10 Agios Pharmaceuticals 1.90 Bn 1.90 Bn 41.75 Mn 51.55 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 51.55 Mn
Mar 31, 2026 48.30 Mn
Dec 31, 2025 51.61 Mn
Sep 30, 2025 41.27 Mn
Jun 30, 2025 45.87 Mn
Mar 31, 2025 41.53 Mn
Dec 31, 2024 51.70 Mn
Sep 30, 2024 38.54 Mn
Jun 30, 2024 35.54 Mn
Mar 31, 2024 31.01 Mn
Dec 31, 2023 35.31 Mn
Sep 30, 2023 25.82 Mn
Jun 30, 2023 30.41 Mn
Mar 31, 2023 28.37 Mn
Dec 31, 2022 32.77 Mn
Sep 30, 2022 29.12 Mn
Jun 30, 2022 28.26 Mn
Mar 31, 2022 31.52 Mn
Dec 31, 2021 31.53 Mn
Sep 30, 2021 27.15 Mn
API Access

Agios Pharmaceuticals Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=AGIO&period=max&api_key=YOUR_API_KEY